
0:00
14:39
Severe refractory asthma, which affects approximately 1% to 5% of patients with asthma, is associated with increased morbidity and mortality. Author Juan Carlos Cardet, MD, MPH, of the University of South Florida joins JAMA Deputy Editor Kristin Walter, MD, MS, to discuss the management of patients with severe refractory asthma, including first-line medications and biologics.
Related Content:
-----------------------------------
Flere episoder fra "JAMA Clinical Reviews"



Gå ikke glip af nogen episoder af “JAMA Clinical Reviews” - abonnér på podcasten med gratisapp GetPodcast.







